Benitec Biopharma's IPO - II Round

Benitec Biopharma raised a round of funding on August 19, 2015. Investors include Public.

Benitec Biopharma (ASX: BLT) (NASDAQ: BNTC) (NASDAQ: BNTCW) is a biotechnology company developing therapeutics based on its patented gene-silencing technology called ddRNAi or 'expressed RNAi'. Based …

Articles about Benitec Biopharma's IPO - II Round: